bluebird bio(us:BLUE)

    7.82

    -8.00%

    Updated on 2024-12-23

    Open:8.43
    Close:7.82
    High:8.45
    Low:7.61
    Pre Close:8.50
    Volume:315490.00
    Amount:2.48M
    Turnover:3.25%
    Shares:9.72M
    MarketCap:76.08M
    Total 3 records
    codechangetotalincreasedecreaserps5rps10rps15rps20

    Biote...

    BK2069

    		+0.60%67230535331142442

    CAR-T...

    BK2113

    		+0.97%109178634643

    Gene ...

    BK2569

    		+0.52%107307821

    About

    bluebird bio, Inc. is a clinical-stage biotechnology company, which engages in researching, developing and commercializing potentially transformative gene therapies for severe genetic diseases. It also offers ZYNTEGLO or beti-cel and SKYSONA or eli-cel gene therapies. The company was founded by Philippe Leboulch and Ronald C. Dorazio on April 16, 1992 and is headquartered in Somerville, MA.
    Address:455 Grand Union Boulevard
    Website:http://www.bluebirdbio.com

    Market Movers